# Distillation Output Examples

Source file: `distillation/distilled_outputs/distill_test_google_medgemma-27b-text-it_20260302T114234Z.jsonl`

| dataset | source_rows | sampled_rows | empty_answer_rate | finish_reason_counts | notes |
|---|---:|---:|---:|---|---|
| afrimedqa_v1_test_3000_with_labels.jsonl | 3000 | 2 | 0.00% | stop:2 | 2 thought-marker answers |
| afrimedqa_v2_full_15275_with_labels.jsonl | 15275 | 2 | 0.00% | stop:2 | 2 thought-marker answers |
| healthsearchqa_3375_no_labels.jsonl | 3375 | 2 | 0.00% | stop:2 | - |
| liveqa_truehealth_635_with_labels.jsonl | 635 | 2 | 0.00% | stop:2 | - |
| medexpqa_train_434.jsonl | 434 | 2 | 0.00% | stop:2 | - |
| medmcqa_with_labels.jsonl | 182822 | 2 | 0.00% | stop:2 | - |
| medqa_with_labels_5opt.jsonl | 10178 | 2 | 0.00% | stop:2 | 2 thought-marker answers |
| pubmedqa_pqa_labeled_1000_medgemma_style_with_labels.jsonl | 1000 | 2 | 0.00% | stop:2 | 2 thought-marker answers |

## Examples

### afrimedqa_v1_test_3000_with_labels.jsonl

- id: `265049d633cd0f3229d266a5284aa104eba52196034cb16afe7a0a70bac253f6`
- true_label: `option4`
- source_row_index: `0`
- question_preview: Question: A 34-year-old man presents with a 1-week history of muscle aches, fatigue, and fever that occurs every 2 days. His history is significant for a trip to Nepal. Vital signs are temperature 39°C (102.2°F), hear...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.629638+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> Correct answer: option4
> Explanation: A patient with recent travel history, cyclical fever, and brick red granules (Schüffner stippling) in erythrocytes suggests the diagnosis of malaria. The patient was most likely treated with chloroquine, a quinoline derivative that is a first-line agent for Plasmodium vivax and P. ovale infections. Chloroquine can cause marked QT prolongation and can cause severe ventricular arrhythmias like torsades de pointes.
> 
> Patients on antimalarials should be monitored with an ECG regularly. The common side effect of chloroquine is gastrointestinal upset (GI), headache, blurred vision, and insomnia.
> 
> Doxycycline and tetracycline are usually well-tolerated, but some GI upset can be seen and, less commonly, ultraviolet photosensitivity
> 
> Metronidazole and pyrimethamine drugs are not effective against malaria.

#### Distilled answer

<unused94>thought
The user wants me to identify the most likely drug administered to a patient based on the clinical presentation and ECG findings.

1.  **Analyze the clinical presentation:**
    *   34-year-old man.
    *   Symptoms: Muscle aches, fatigue, fever (every 2 days - tertian fever pattern).
    *   History: Trip to Nepal (malaria-endemic region).
    *   Vital signs: Fever (39°C), tachycardia (102 bpm), tachypnea (22 breaths/min), slightly low BP (108/74 mm Hg).
    *   Physical exam: Icterus (jaundice), splenomegaly.
    *   Labs: Anemia (Hb 11 g/dL), peripheral smear shows erythrocytes with brick-red granules (Schüffner's dots, characteristic of *Plasmodium vivax* or *Plasmodium ovale*).
    *   Presumptive diagnosis: Malaria, likely *P. vivax* or *P. ovale* given the tertian fever and Schüffner's dots.

2.  **Identify the likely treatment:**
    *   The patient has malaria, likely *P. vivax* or *P. ovale*.
    *   Treatment for malaria typically involves:
        *   Blood schizonticide (to treat the acute infection): Chloroquine (if sensitive), artemisinins, quinine, mefloquine, doxycycline, atovaquone/proguanil.
        *   Hypnozoite eradication (for *P. vivax* and *P. ovale* to prevent relapse): Primaquine or tafenoquine.
    *   Given the severity (fever, tachycardia, tachypnea, anemia, icterus), hospitalization and intravenous therapy might be considered initially, but oral therapy is also common.
    *   Chloroquine is a common first-line treatment for sensitive *P. vivax* and *P. ovale* malaria. Doxycycline is often used in combination or as an alternative. Primaquine is used for radical cure. Metronidazole is for anaerobic infections/protozoa like *Giardia* or *Trichomonas*. Pyrimethamine is used for toxoplasmosis or sometimes in combination for malaria (e.g., with sulfadoxine). Ciprofloxacin is an antibiotic.

3.  **Analyze the complication:**
    *   On the 3rd hospital day, the patient develops a sudden increase in heart rate.
    *   An ECG is obtained (although the ECG image is not provided in the text, the question implies it shows a specific abnormality related to the drug).
    *   The question asks for the *most likely* drug administered that could cause this complication.

4.  **Evaluate the options in the context of the clinical picture and potential ECG changes:**
    *   **Metronidazole:** Primarily used for anaerobic bacteria and protozoa. Not a standard malaria treatment. Side effects include nausea, metallic taste, peripheral neuropathy, disulfiram-like reaction. Cardiac effects are rare.
    *   **Pyrimethamine:** Used for toxoplasmosis, sometimes malaria. Side effects include bone marrow suppression, hypersensitivity reactions. Cardiac effects are not typical.
    *   **Ciprofloxacin:** Antibiotic. Not used for malaria treatment. Side effects include GI upset, CNS effects, tendon rupture. Cardiac effects include QT prolongation, but less commonly associated with sudden tachycardia in this context.
    *   **Chloroquine:** A common antimalarial, especially for *P. vivax* and *P. ovale*. Known cardiac side effects include:
        *   **QT prolongation:** Can lead to torsades de pointes (a polymorphic ventricular tachycardia).
        *   **Bradycardia:** Can occur, but tachycardia is also possible, especially if QT prolongation leads to arrhythmias.
        *   **Cardiomyopathy:** With long-term use.
        *   **Conduction abnormalities.**
        *   Sudden cardiac death has been reported.
        *   *Given the sudden increase in heart rate, QT prolongation leading to ventricular tachycardia is a plausible complication.*
    *   **Doxycycline:** A tetracycline antibiotic, used for malaria prophylaxis and treatment. Side effects include GI upset, photosensitivity, esophageal irritation. Cardiac effects are rare but can include pericarditis or cardiomyopathy in some cases. QT prolongation is less common than with chloroquine.

5.  **Synthesize the information:**
    *   The patient likely has *P. vivax* or *P. ovale* malaria.
    *   Chloroquine is a very common treatment for this type of malaria.
    *   Chloroquine is well-known to cause QT prolongation and potentially life-threatening arrhythmias like torsades de pointes, which can manifest as sudden tachycardia or ventricular tachycardia.
    *   While other drugs *could* potentially cause cardiac issues, chloroquine is the most strongly associated with significant ECG changes (like QT prolongation) and arrhythmias in the context of malaria treatment.
    *   The sudden increase in heart rate strongly suggests an arrhythmia, which is a known complication of chloroquine.

6.  **Conclusion:** Based on the clinical presentation suggestive of *P. vivax* or *P. ovale* malaria and the known cardiac side effects of antimalarial drugs, chloroquine is the most likely drug administered that could cause a sudden increase in heart rate due to QT prolongation and subsequent arrhythmia.<unused95>*   **Clinical Presentation Analysis:** The patient presents with symptoms (fever every 2 days, muscle aches, fatigue), signs (icterus, splenomegaly), and laboratory findings (anemia, Schüffner's dots on peripheral smear) highly suggestive of *Plasmodium vivax* or *Plasmodium ovale* malaria. The history of travel to Nepal further supports this diagnosis. The tertian fever pattern (every 48 hours) is characteristic of these species. Schüffner's dots are also typical for *P. vivax* and *P. ovale*.

*   **Treatment Considerations:** Standard treatment for uncomplicated *P. vivax* or *P. ovale* malaria typically involves a blood schizonticide followed by a hypnozoite eradicating agent (like primaquine) to prevent relapse. Chloroquine is a common blood schizonticide for chloroquine-sensitive strains of *P. vivax* and *P. ovale*. Doxycycline is another option, often used in combination or for resistant strains. Primaquine is used for radical cure. Metronidazole, pyrimethamine, and ciprofloxacin are not primary treatments for this type of malaria.

*   **Complication Analysis:** The patient developed a sudden increase in heart rate on the 3rd day of treatment. This suggests a cardiac arrhythmia. We need to identify which of the potential antimalarial drugs is most commonly associated with significant cardiac side effects, particularly arrhythmias.

*   **Evaluating Drug Side Effects:**
    *   **Metronidazole:** Not typically used for malaria. Cardiac side effects are rare.
    *   **Pyrimethamine:** Not typically used as monotherapy for malaria. Cardiac side effects are not common.
    *   **Ciprofloxacin:** An antibiotic, not used for malaria. Can cause QT prolongation, but less commonly associated with acute arrhythmias in this context compared to other options.
    *   **Chloroquine:** A well-known antimalarial. It has significant potential cardiac toxicity, including QT interval prolongation, which can lead to potentially fatal ventricular arrhythmias like torsades de pointes. These arrhythmias can manifest as palpitations, dizziness, syncope, or sudden cardiac arrest, often presenting with tachycardia.
    *   **Doxycycline:** Used for malaria. Cardiac side effects are uncommon but can occur. QT prolongation is less frequently associated with doxycycline compared to chloroquine.

*   **Conclusion:** Given the clinical picture of likely *P. vivax* or *P. ovale* malaria and the development of a sudden increase in heart rate (suggesting an arrhythmia), chloroquine is the most likely drug administered among the options, as it is a common treatment for this condition and is well-known for causing QT prolongation and associated arrhythmias. The ECG (though not shown) would likely demonstrate QT prolongation or evidence of ventricular tachycardia if chloroquine toxicity is the cause.

Final Answer: The final answer is $\boxed{Chloroquine}$

### afrimedqa_v2_full_15275_with_labels.jsonl

- id: `ff784abc6b461a6a15d7f8bf5e6560d3393474fe4748699ff4c7f2124292b95f`
- true_label: `None`
- source_row_index: `0`
- question_preview: Prompt: Your female friend complains of weight gain, high blood pressure and thinks she has Lupus Nephritis and is going to visit the nearest doctor. Question: Question: Can you provide recommendations for managing st...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.629725+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

_(no source assistant answer found for this sample)_

#### Distilled answer

<unused94>thought
Here's a thinking process for responding to the user's request:

1.  **Identify the Core Problem:** The user's friend is experiencing symptoms (weight gain, high blood pressure) and *believes* she has Lupus Nephritis. She's seeking advice on stress management and mental well-being *in relation to her condition*.

2.  **Acknowledge and Validate:** Start by acknowledging the friend's concerns. It's important to show empathy and validate that her feelings are real and understandable. Phrases like "It's completely understandable..." or "Dealing with these symptoms..." work well.

3.  **Address the Self-Diagnosis Issue (Gently but Firmly):** The friend *thinks* she has Lupus Nephritis. This is a serious condition requiring professional diagnosis. It's crucial *not* to confirm or deny her self-diagnosis but to emphasize the importance of seeing a doctor. This is the most critical piece of advice.
    *   *Why is this important?* Lupus Nephritis is a serious autoimmune disease affecting the kidneys. Self-diagnosis can lead to delayed treatment, incorrect treatment, or unnecessary anxiety.
    *   *How to phrase it?* "It's really important that she sees a doctor..." "Only a medical professional can accurately diagnose..." "Getting a proper diagnosis is the first step..."

4.  **Connect Stress/Mental Well-being to the Symptoms/Condition:** The user specifically asked for stress management advice *in relation to her condition*.
    *   *How does stress relate?* Stress can exacerbate symptoms like high blood pressure. It can also impact overall health and make managing any chronic condition more difficult. It can also contribute to weight gain (stress eating, hormonal changes).
    *   *How does mental well-being relate?* Living with chronic illness (or the *fear* of having one) is mentally taxing. Anxiety, depression, and fear are common. Addressing mental well-being is crucial for coping and adherence to treatment.

5.  **Brainstorm Stress Management Techniques:** Think of common, evidence-based stress reduction methods. Categorize them for clarity.
    *   **Mindfulness/Relaxation:** Deep breathing, meditation, yoga, progressive muscle relaxation.
    *   **Physical Activity:** Exercise (gentle, as appropriate – *important caveat*), walking, stretching.
    *   **Social Support:** Talking to friends, family, support groups.
    *   **Hobbies/Enjoyment:** Engaging in activities she enjoys, creative outlets.
    *   **Sleep:** Prioritizing good sleep hygiene.
    *   **Time Management/Boundaries:** Learning to say no, organizing tasks.
    *   **Professional Help:** Therapy, counseling.

6.  **Tailor Advice to the *Potential* Condition (Lupus Nephritis):** While avoiding diagnosis, consider how stress management might be particularly relevant if she *does* have a chronic condition like Lupus.
    *   *Flare-ups:* Stress can sometimes trigger flares in autoimmune diseases. Managing stress might help reduce flare frequency/severity (though this needs medical confirmation).
    *   *Adherence:* Mental well-being supports adherence to medication and lifestyle changes.
    *   *Coping:* Provides tools to cope with the emotional burden of a chronic illness.

7.  **Structure the Response:**
    *   **Empathy/Validation:** Start by acknowledging her feelings.
    *   **Prioritize Medical Consultation:** Strongly emphasize seeing a doctor for diagnosis and treatment. This is non-negotiable.
    *   **Explain the Link:** Briefly explain *why* stress management is important in this context (impact on BP, overall health, coping).
    *   **Provide Specific Recommendations:** List the stress management techniques, perhaps grouped logically. Add brief explanations for each.
    *   **Add Important Caveats:**
        *   Mention that these are general suggestions and should be discussed with her doctor, especially regarding exercise given her symptoms (weight gain, high BP).
        *   Reiterate that these techniques *complement*, not *replace*, medical care.
        *   Encourage seeking professional mental health support if needed.
    *   **Offer Support:** End with a supportive message for the user and their friend.

8.  **Refine Language:**
    *   Use supportive and encouraging language.
    *   Avoid medical jargon where possible.
    *   Be clear and concise.
    *   Ensure the tone is helpful and non-judgmental.
    *   *Crucially*, avoid giving medical advice or confirming the suspected diagnosis. Frame everything as general well-being strategies *while waiting for/alongside* medical care. Use phrases like "It might be helpful to..." or "Consider exploring..."

9.  **Self-Correction/Review:** Read through the response. Does it directly answer the user's question? Does it prioritize the need for medical diagnosis? Is the advice safe and general? Is the tone appropriate? *Yes, it addresses stress management in relation to the situation, emphasizes seeing a doctor, and provides actionable, general tips.*<unused95>Okay, it's completely understandable that your friend is feeling stressed and worried, especially with symptoms like weight gain and high blood pressure, and the concern about Lupus Nephritis. It's great that she's planning to see a doctor – that's the most important first step for getting an accurate diagnosis and appropriate care.

While I cannot provide medical advice or confirm any diagnosis (only a doctor can do that after proper testing), I can offer some general recommendations for managing stress and improving mental well-being that can be helpful *alongside* medical care, regardless of the underlying cause of her symptoms. These are things she can discuss with her doctor as well.

**Important First Step:** Encourage her to be open and honest with the doctor about *all* her symptoms, her concerns about Lupus Nephritis, and how she's feeling emotionally. This information is crucial for the doctor to provide the best care.

**Stress Management & Mental Well-being Recommendations:**

1.  **Acknowledge and Validate Feelings:** It's okay to feel scared, anxious, or overwhelmed. Recognizing these feelings without judgment is the first step. Encourage her to talk about how she's feeling with you or other trusted friends/family.

2.  **Mindfulness and Relaxation Techniques:**
    *   **Deep Breathing:** Simple exercises like taking slow, deep breaths can calm the nervous system quickly. (e.g., inhale slowly for 4 counts, hold for 4, exhale slowly for 6).
    *   **Meditation/Mindfulness Apps:** Apps like Calm, Headspace, or Insight Timer offer guided meditations for stress, anxiety, and sleep. Even 5-10 minutes a day can make a difference.
    *   **Progressive Muscle Relaxation:** Tensing and then releasing different muscle groups can help reduce physical tension associated with stress.

3.  **Gentle Physical Activity:**
    *   **Walking:** Even short walks outdoors can improve mood and reduce stress.
    *   **Yoga or Tai Chi:** These combine physical movement, breathing, and meditation, which are excellent for stress relief.
    *   **Important Note:** Given her high blood pressure and weight gain, she should *discuss any exercise plans with her doctor* before starting, to ensure it's safe and appropriate for her specific situation.

4.  **Prioritize Sleep:** Stress often disrupts sleep, and poor sleep worsens stress.
    *   **Consistent Schedule:** Try to go to bed and wake up around the same time each day.
    *   **Relaxing Bedtime Routine:** A warm bath, reading a book (not on a screen), or listening to calming music can help wind down.
    *   **Optimize Sleep Environment:** Make sure the bedroom is dark, quiet, and cool.

5.  **Healthy Diet (as advised by doctor):** While she's concerned about weight gain, focusing on stress-reducing foods (like those rich in omega-3s, magnesium, and B vitamins) can be helpful. *Crucially, she should follow dietary advice from her doctor, especially considering her high blood pressure.* Stress can sometimes lead to emotional eating, so being mindful of eating habits is important.

6.  **Social Support:**
    *   **Talk to Loved Ones:** Sharing her worries with supportive friends or family can provide comfort and perspective.
    *   **Support Groups:** If she does receive a diagnosis like Lupus, connecting with others who have similar experiences can be incredibly helpful (online or in-person groups).

7.  **Limit Stressors Where Possible:**
    *   **News/Social Media:** If constant exposure to negative news or social media is increasing her anxiety, encourage her to limit her intake.
    *   **Saying No:** Learning to set boundaries and say no to extra commitments can prevent feeling overwhelmed.

8.  **Engage in Enjoyable Activities:** Make time for hobbies or activities she genuinely enjoys, even if it's just for a short period each day. This helps shift focus away from worries.

9.  **Professional Mental Health Support:** If stress and anxiety feel overwhelming or persistent, encourage her to consider talking to a therapist or counselor. They can provide coping strategies tailored to her specific situation. This is especially important if she receives a chronic illness diagnosis.

**Key Takeaway:**

The most crucial thing right now is for her to see the doctor. These stress management techniques are supportive tools, but they are *not* a substitute for medical diagnosis and treatment. They can help her cope while she seeks answers and works with her healthcare provider. Be a supportive friend by listening and encouraging her to take that important step.

### healthsearchqa_3375_no_labels.jsonl

- id: `1`
- true_label: `None`
- source_row_index: `0`
- question_preview: Are benign brain tumors serious?
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.629782+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

_(no source assistant answer found for this sample)_

#### Distilled answer

Yes, benign brain tumors can be serious, even though they are not cancerous. Here's a breakdown of why:

*   **Location:** The brain is a confined space. Even a slow-growing benign tumor can press on critical areas, disrupting normal brain function. This can lead to symptoms like headaches, seizures, vision problems, balance issues, personality changes, and more, depending on the location.
*   **Size:** As benign tumors grow, they can increase pressure inside the skull (intracranial pressure). This pressure can cause severe headaches, nausea, vomiting, and potentially life-threatening complications like brain herniation.
*   **Inoperability:** Some benign tumors are located in areas of the brain that are difficult or impossible to remove surgically without causing significant damage to vital functions (like speech, movement, or vision).
*   **Recurrence:** While not cancerous, some benign tumors can grow back after being removed.
*   **Impact on Quality of Life:** The symptoms caused by a benign brain tumor can significantly impact a person's daily life, ability to work, and overall well-being.
*   **Potential for Malignant Transformation:** Although rare, some types of benign brain tumors can, over time, transform into malignant (cancerous) tumors.

**In summary:** While "benign" means the tumor cells are not cancerous and don't spread to other parts of the body, their location within the brain makes them potentially very serious and life-threatening due to the pressure they can exert and the functions they can interfere with. Treatment is often necessary to manage symptoms, prevent complications, and improve quality of life.

### liveqa_truehealth_635_with_labels.jsonl

- id: `1`
- true_label: `Cardiac amyloidosis is a disorder caused by deposits of an abnormal protein (amyloid) in the heart tissue. These deposits make it hard for the heart to work properly.`
- source_row_index: `0`
- question_preview: Literature on Cardiac amyloidosis. Please let me know where I can get literature on Cardiac amyloidosis. My uncle died yesterday from this disorder. Since this is such a rare disorder, and to honor his memory, I would...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.629833+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> Cardiac amyloidosis is a disorder caused by deposits of an abnormal protein (amyloid) in the heart tissue. These deposits make it hard for the heart to work properly.

#### Distilled answer

I am so sorry to hear about the loss of your uncle. It's a thoughtful gesture to want to share information about cardiac amyloidosis at his service to honor his memory and raise awareness.

Given your background and location, here are several resources and suggestions for obtaining literature on cardiac amyloidosis, including options at NIH:

**1. National Heart, Lung, and Blood Institute (NHLBI) - Part of NIH:**

*   **Website:** The NHLBI website has extensive information on various heart conditions, including amyloidosis. Search for "cardiac amyloidosis" on their site ([https://www.nhlbi.nih.gov/](https://www.nhlbi.nih.gov/)). They often have fact sheets, summaries, and links to other resources.
*   **Publications:** NHLBI publishes patient-friendly materials. You can search their publications database online or inquire directly with their health information office.
*   **Contact:** You can call the NHLBI Health Information Center at 301-592-8599 or email NHLBIinfo@mail.nih.gov. Explain your situation and ask if they have printed materials suitable for distribution at a funeral service. They may be able to provide brochures or fact sheets.

**2. National Institute on Aging (NIA) - Part of NIH:**

*   **Website:** Since amyloidosis can affect older adults, the NIA might have relevant information, particularly regarding diagnosis and management in the elderly. Check their website ([https://www.nia.nih.gov/](https://www.nia.nih.gov/)).
*   **Contact:** Similar to NHLBI, you can contact the NIA Information Center at 1-800-222-2225 or via their website contact form.

**3. Amyloidosis Foundation:**

*   **Website:** This is a leading non-profit organization dedicated to amyloidosis research, education, and patient support. Their website ([https://www.amyloidosis.org/](https://www.amyloidosis.org/)) is a wealth of information.
*   **Literature:** They offer brochures, fact sheets, and other educational materials specifically about amyloidosis, including cardiac amyloidosis. They often have materials available for download or can mail printed copies. You can contact them directly through their website to request materials for distribution.

**4. American Heart Association (AHA):**

*   **Website:** The AHA provides information on various cardiovascular diseases. Search their site ([https://www.heart.org/](https://www.heart.org/)) for "cardiac amyloidosis."
*   **Literature:** They may have brochures or fact sheets available for download or order.

**5. Mayo Clinic and Cleveland Clinic:**

*   **Websites:** These major medical centers have excellent, patient-friendly information on cardiac amyloidosis on their websites ([https://www.mayoclinic.org/](https://www.mayoclinic.org/), [https://my.clevelandclinic.org/](https://my.clevelandclinic.org/)).
*   **Literature:** They often have downloadable or orderable patient education materials.

**6. PubMed Central (PMC) / National Library of Medicine (NLM) - Part of NIH:**

*   **Website:** While more technical, PMC ([https://www.ncbi.nlm.nih.gov/pmc/](https://www.ncbi.nlm.nih.gov/pmc/)) archives full-text biomedical literature. You might find review articles or summaries that could be adapted, but these are generally not suitable for a general audience at a funeral.
*   **NLM:** The NLM itself ([https://www.nlm.nih.gov/](https://www.nlm.nih.gov/)) is a resource, but primarily for researchers and healthcare professionals.

**Recommendations for Funeral Service Literature:**

*   **Focus on Simplicity:** Choose materials that are easy to understand for a general audience, avoiding overly technical jargon.
*   **Key Information:** Include basic information about what cardiac amyloidosis is, common symptoms (shortness of breath, fatigue, swelling), the importance of early diagnosis, and current treatment approaches (even if brief).
*   **Resources:** Provide contact information for organizations like the Amyloidosis Foundation where people can learn more.
*   **Tone:** Keep the tone informative and hopeful, focusing on awareness and the progress being made in understanding and treating the disease.
*   **Personal Touch:** Consider adding a brief, personal note about your uncle and why raising awareness is important to you.

**Action Steps:**

1.  **Contact NHLBI:** Given your NIH background, this is a good first step. Call or email their health information office to inquire about available printed materials.
2.  **Contact Amyloidosis Foundation:** They specialize in this condition and are likely to have suitable materials readily available.
3.  **Review Online Resources:** Browse the websites mentioned above to get a feel for the information available and identify specific brochures or fact sheets that might be appropriate.
4.  **Order/Download:** Order printed materials or download PDFs that you can print yourself. Allow sufficient time for shipping if ordering.

Again, my deepest condolences on the loss of your uncle. Your desire to honor him by raising awareness is a wonderful tribute.

### medexpqa_train_434.jsonl

- id: `None`
- true_label: `None`
- source_row_index: `0`
- question_preview: Juan, a second year resident, attends Sofia, a 15 year old girl in the emergency room, who apparently fainted at school without losing consciousness. The patient says that she was due to take an exam, which caused her...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.629044+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> There is no doubt that the doctor-patient relationship today transcends the physical environment of the consultation room. But we must not forget that we must maintain the same ethical and professional codes as in the real environment. The code of ethics Article 26-3. The clinical practice of medicine by means of consultations exclusively by letter, telephone, radio, press or internet, is contrary to the deontological norms. [HIDDEN] the personal and direct contact between the doctor and the patient.

#### Distilled answer

This is a classic ethical dilemma in medicine, highlighting the importance of maintaining professional boundaries. Here's a breakdown of the situation and the best response for Juan:

**Analysis of the Situation:**

*   **Power Imbalance:** Juan is a physician (resident), and Sofia is a patient, a minor (15 years old). This creates an inherent power imbalance. Juan has authority and responsibility for Sofia's care.
*   **Vulnerability:** Sofia is in the ER, likely feeling anxious, scared, and possibly vulnerable due to the fainting episode, bullying, and potential eating disorder. She's also a minor, making her particularly susceptible to influence.
*   **Boundary Crossing:** Juan's initial attempt to connect by sharing his own social media use was a subtle boundary crossing. While perhaps intended to be reassuring, it blurred the lines between doctor and patient.
*   **Sofia's Request:** Sofia's request to add Juan on Facebook is a direct attempt to establish a personal, social relationship outside the professional context. Accepting this would be a significant breach of professional boundaries.
*   **Potential Harms:** Accepting the friend request could lead to:
    *   **Compromised Objectivity:** Juan might be influenced in his clinical judgment by a personal relationship.
    *   **Exploitation:** The power imbalance makes the relationship potentially exploitative, even if unintended.
    *   **Confidentiality Issues:** Social media interactions can inadvertently reveal patient information or create expectations of confidentiality that are inappropriate in a social context.
    *   **Professional Misconduct:** This could be viewed as unprofessional behavior and potentially lead to disciplinary action.
    *   **Damage to Therapeutic Relationship:** While Juan tried to be friendly, accepting the request could undermine the trust necessary for effective medical care. Sofia might feel uncomfortable sharing sensitive information later.

**Juan's Best Response:**

Juan needs to firmly but kindly decline the request while reinforcing the professional boundaries. Here are a few options, ranging from good to best:

**Option 1 (Good, but could be improved):** "I appreciate the thought, Sofia, but I don't think it's appropriate for us to be friends on Facebook. It's important for me to maintain a professional relationship with my patients."

*   **Pros:** Clear, direct, states the reason.
*   **Cons:** A bit blunt, might feel dismissive to Sofia.

**Option 2 (Better):** "That's very kind of you to offer, Sofia. However, as your doctor, it's really important that we keep our relationship professional. Connecting on social media isn't something I do with patients. I need to make sure I can focus completely on your health and well-being here."

*   **Pros:** Polite, acknowledges the offer, clearly states the boundary, explains the reasoning (focus on care), avoids making it personal ("I don't do this with *any* patient").
*   **Cons:** Still a bit formal.

**Option 3 (Best - Empathetic and Firm):** "I really appreciate you thinking of me, Sofia, and it's nice to know you're feeling better. However, it's important for me to maintain a professional boundary as your doctor. Connecting on social media like Facebook isn't appropriate between a doctor and a patient. My role here is to take care of your health, and that works best when we keep our relationship focused on that. I hope you understand."

*   **Pros:**
    *   **Acknowledges and validates:** "I really appreciate you thinking of me..." and "it's nice to know you're feeling better." This shows empathy.
    *   **Clear boundary:** "...it's important for me to maintain a professional boundary..."
    *   **States the rule:** "...connecting on social media... isn't appropriate between a doctor and a patient."
    *   **Explains the rationale:** "...My role here is to take care of your health, and that works best when we keep our relationship focused on that."
    *   **Polite closing:** "I hope you understand."
    *   **Avoids personal justification:** Doesn't say "I don't use social media" or "I don't do this with anyone," which could be debated. It focuses on the *professional* reason.

**Key Elements of the Best Response:**

1.  **Acknowledge and Validate:** Show appreciation for the gesture.
2.  **State the Boundary Clearly:** Explicitly say that connecting on social media is not appropriate.
3.  **Explain the Rationale:** Briefly explain *why* (professionalism, focus on care, maintaining appropriate doctor-patient relationship).
4.  **Be Firm but Kind:** The tone should be polite and empathetic, not dismissive or cold.
5.  **Avoid Personal Justifications:** Focus on professional guidelines, not personal preferences.
6.  **Redirect (Optional but helpful):** After declining, Juan should redirect the conversation back to Sofia's health or comfort in the ER. "Now, how are you feeling? Is there anything else I can get for you?"

**Why Juan's initial sharing was problematic:**

While Juan's intention might have been good, sharing personal information about his social media use was a step towards blurring boundaries. It created a false sense of equality and familiarity. It's generally best for physicians to maintain a professional distance and avoid excessive self-disclosure, especially with vulnerable patients.

**In conclusion, Juan's best response is Option 3, as it is empathetic, clear, firm, and professionally appropriate.** He must prioritize maintaining the integrity of the doctor-patient relationship.

### medmcqa_with_labels.jsonl

- id: `301b5d37-ac36-4429-98aa-16a6ca7f0669`
- true_label: `C`
- true_label_idx: `2`
- source_row_index: `0`
- question_preview: Schistosomiasis is transmitted by ? A. Cyclops B. Fish C. Snaile D. Cattle
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.627822+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> **Transmission of Schistosomiasis**
> 
> Schistosomiasis, also known as bilharzia, is a parasitic disease caused by Schistosoma species. The transmission of this disease involves a complex life cycle involving both a definitive host and an intermediate host.
> 
> ### Life Cycle of Schistosomiasis
> 
> - **Definitive Host:** Humans are the definitive hosts for Schistosoma species.
> - **Intermediate Host:** The intermediate host for Schistosoma species is a type of snail. These snails are responsible for harboring the larval stages of the parasite.
> 
> ### How Transmission Occurs
> 
> - **Infection Begins:** The life cycle of Schistosomiasis begins when an infected snail releases cercariae, the larval stages of the parasite, into the water.
> - **Human Infection:** Humans become infected when they come into contact with contaminated water while swimming or wading. The cercariae penetrate the skin, and the larvae mature into adult worms in the human host.
> 
> ### Conclusion
> 
> The intermediate host for Schistosoma species is a snail, which plays a crucial role in the transmission of the disease.
> 
> ### Answer:
> C. Snail

#### Distilled answer

The correct answer is **C. Snail**.

Here's why:

*   **Schistosomiasis (Bilharzia)** is a parasitic disease caused by trematode worms (flukes) of the genus *Schistosoma*.
*   The life cycle of *Schistosoma* involves two hosts: a human (definitive host) and a specific species of freshwater **snail** (intermediate host).
*   Humans become infected when larval forms of the parasite, called cercariae, released by infected snails, penetrate their skin during contact with infested water.

Let's look at the other options:

*   **A. Cyclops:** These are tiny crustaceans that act as intermediate hosts for *Dracunculus medinensis* (guinea worm) and some tapeworms like *Diphyllobothrium latum* (fish tapeworm), but not *Schistosoma*.
*   **B. Fish:** Fish can be intermediate hosts for various parasites, including *Clonorchis sinensis* (Chinese liver fluke) and *Diphyllobothrium latum*, but not *Schistosoma*.
*   **D. Cattle:** Cattle can be hosts for various parasites, including *Taenia saginata* (beef tapeworm), but they are not involved in the transmission cycle of schistosomiasis to humans.

### medqa_with_labels_5opt.jsonl

- id: `1`
- true_label: `E`
- true_answer_text: `Nitrofurantoin`
- source_row_index: `0`
- question_preview: Question: A 23-year-old pregnant woman at 22 weeks gestation presents with burning upon urination. She states it started 1 day ago and has been worsening despite drinking more water and taking cranberry extract. She o...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.620578+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> To determine the best treatment for this pregnant woman with symptoms suggestive of a urinary tract infection (UTI), we'll need to consider the safety and efficacy of potential antibiotics during pregnancy. Here is the step-by-step rationale:
> 
> 1. **Evaluate the Symptoms and Diagnosis**:
>    - The patient has burning upon urination, which began 1 day ago and has worsened.
>    - She has no fever or other signs of systemic illness.
>    - Absence of costovertebral angle tenderness points away from pyelonephritis and supports a diagnosis of cystitis (bladder infection).
> 
> 2. **Consider Patient’s Demographic and Pregnant State**:
>    - The patient is pregnant (22 weeks gestation).
>    - Safety of antibiotic use in pregnancy is crucial to avoid harm to both the mother and fetus.
> 
> 3. **Review Antibiotic Options and Pregnancy Safety**:
>    - **Ampicillin**: Generally safe in pregnancy but less commonly used for UTIs due to resistance.
>    - **Ceftriaxone**: Used for more severe infections like pyelonephritis or other systemic infections and is typically not first-line for uncomplicated cystitis.
>    - **Ciprofloxacin**: A fluoroquinolone, contraindicated in pregnancy due to potential harm to fetal cartilage development.
>    - **Doxycycline**: A tetracycline, contraindicated in pregnancy as it can affect fetal bone growth and tooth discoloration.
>    - **Nitrofurantoin**: Broadly used for uncomplicated UTIs and generally considered safe in most stages of pregnancy, except near term due to the risk of neonatal hemolysis.
> 
> 4. **Best Treatment Selection**:
>    - **Ampicillin**: Not preferred due to resistance issues.
>    - **Ceftriaxone**: More suited for severe cases and not first-line for simple cystitis.
>    - **Ciprofloxacin and Doxycycline**: Both are contraindicated in pregnancy.
>    - **Nitrofurantoin**: Effective for uncomplicated cystitis and safe in pregnancy (particularly up to the last weeks before term).
> 
> Considering all the above points, **E. Nitrofurantoin** is the best treatment option for this patient's uncomplicated cystitis, balancing effectiveness and safety during pregnancy.
> **Answer**: E. Nitrofurantoin

#### Distilled answer

<unused94>thought
The user wants to identify the best antibiotic treatment for a pregnant woman at 22 weeks gestation presenting with symptoms of a urinary tract infection (UTI), specifically dysuria (burning upon urination).

1.  **Identify the condition:** The patient presents with dysuria, a classic symptom of a lower UTI (cystitis). She is pregnant, which increases the risk of UTIs and potential complications like pyelonephritis. Her vital signs are stable, and she lacks costovertebral angle tenderness, suggesting the infection is likely confined to the lower urinary tract (cystitis) rather than the upper tract (pyelonephritis).

2.  **Consider the patient population:** The patient is pregnant (22 weeks gestation). This is a crucial factor because many antibiotics are contraindicated or require caution during pregnancy due to potential harm to the fetus.

3.  **Evaluate the antibiotic options:**
    *   **A. Ampicillin:** While historically used, resistance rates to ampicillin are high for common UTI pathogens like *E. coli*. It's generally not a first-line choice for empiric UTI treatment, especially in pregnancy where safer and more effective options exist.
    *   **B. Ceftriaxone:** This is a third-generation cephalosporin, typically administered parenterally (IV or IM). It's often used for more severe infections like pyelonephritis or complicated UTIs, or when oral options are not suitable. It is generally considered safe in pregnancy (Category B), but it's not a standard first-line oral treatment for uncomplicated cystitis.
    *   **C. Ciprofloxacin:** This is a fluoroquinolone. Fluoroquinolones are generally contraindicated during pregnancy (Category C) due to concerns about potential cartilage damage in the fetus, although human data is somewhat conflicting. They are typically reserved for situations where other safer options are not feasible.
    *   **D. Doxycycline:** This is a tetracycline. Tetracyclines are contraindicated during pregnancy (Category D) because they can cause permanent discoloration of fetal teeth and may affect bone development.
    *   **E. Nitrofurantoin:** This antibiotic is commonly used to treat uncomplicated cystitis. It concentrates well in the urine and has relatively low systemic absorption, minimizing fetal exposure. It is generally considered safe for use during the first and second trimesters of pregnancy (Category B). However, it should typically be avoided near term (after 37 weeks) due to a theoretical risk of hemolytic anemia in the newborn. Since the patient is at 22 weeks, nitrofurantoin is a suitable option.

4.  **Compare suitable options:** Nitrofurantoin is a standard first-line treatment for uncomplicated cystitis in pregnancy during the first and second trimesters. Other options often considered include cephalexin and amoxicillin-clavulanate. Ampicillin has high resistance rates. Ceftriaxone is usually for more severe infections. Ciprofloxacin and Doxycycline are contraindicated or generally avoided.

5.  **Select the best option:** Based on safety profile in the second trimester and efficacy for uncomplicated cystitis, Nitrofurantoin is the most appropriate choice among the given options.<unused95>*   **Rationale Breakdown:**
    *   The patient is pregnant (22 weeks) and presents with symptoms consistent with uncomplicated cystitis (dysuria without fever or flank pain).
    *   Treatment of UTI in pregnancy is crucial to prevent complications like pyelonephritis, preterm labor, and low birth weight.
    *   Antibiotic choice must consider both efficacy against common uropathogens (like *E. coli*) and safety during pregnancy.
    *   **Ampicillin (A):** High rates of resistance among uropathogens limit its use as empiric therapy.
    *   **Ceftriaxone (B):** A broad-spectrum cephalosporin, generally safe in pregnancy (Category B), but typically reserved for pyelonephritis or complicated UTIs requiring parenteral therapy, not first-line for uncomplicated cystitis.
    *   **Ciprofloxacin (C):** A fluoroquinolone. Fluoroquinolones are generally avoided in pregnancy (Category C) due to potential risks to fetal cartilage development, although data is somewhat conflicting. They are not a first-line choice.
    *   **Doxycycline (D):** A tetracycline. Tetracyclines are contraindicated in pregnancy (Category D) due to risks of fetal tooth discoloration and bone development issues.
    *   **Nitrofurantoin (E):** Commonly used for uncomplicated cystitis. It concentrates well in the urine and has minimal systemic effects. It is considered safe during the first and second trimesters (Category B). It should be avoided near term (after 37 weeks) due to a potential risk of hemolytic anemia in newborns with G6PD deficiency. Since the patient is at 22 weeks, nitrofurantoin is a safe and effective first-line option. Other first-line options for uncomplicated cystitis in pregnancy include cephalexin and amoxicillin-clavulanate, but among the choices provided, nitrofurantoin is the best fit.

*   **Conclusion:** Nitrofurantoin is a recommended first-line agent for uncomplicated cystitis in the second trimester of pregnancy.

**Final Answer: The final answer is $\boxed{E}$**

### pubmedqa_pqa_labeled_1000_medgemma_style_with_labels.jsonl

- id: `21645374`
- true_label: `yes`
- source_row_index: `0`
- question_preview: Context: Programmed cell death (PCD) is the regulated death of cells within an organism. The lace plant (Aponogeton madagascariensis) produces perforations in its leaves through PCD. The leaves of the plant consist of...
- distilled_model: `google/medgemma-27b-text-it`
- distilled_timestamp_utc: `2026-03-02T11:42:02.628508+00:00`
- distilled_finish_reason: `stop`

#### Source answer(s)

> Results depicted mitochondrial dynamics in vivo as PCD progresses within the lace plant, and highlight the correlation of this organelle with other organelles during developmental PCD. To the best of our knowledge, this is the first report of mitochondria and chloroplasts moving on transvacuolar strands to form a ring structure surrounding the nucleus during developmental PCD. Also, for the first time, we have shown the feasibility for the use of CsA in a whole plant system. Overall, our findings implicate the mitochondria as playing a critical and early role in developmentally regulated PCD in the lace plant.

#### Distilled answer

<unused94>thought
1.  **Identify the core question:** The question asks if mitochondria play a role in remodeling lace plant leaves during programmed cell death (PCD).

2.  **Scan the text for keywords:** Look for "mitochondria," "programmed cell death," "PCD," "lace plant," "Aponogeton madagascariensis," "remodeling," "leaves," "role."

3.  **Analyze the text for evidence related to mitochondria and PCD:**
    *   The text explicitly states the paper "elucidates the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis." This directly addresses the role of mitochondria in PCD in this plant.
    *   The study divides cells based on PCD progression (NPCD, EPCD, LPCD).
    *   Mitochondria were stained (MitoTracker Red CMXRos) and their dynamics categorized (M1-M4) based on distribution, motility, and membrane potential (ΔΨm).
    *   A correlation was found between mitochondrial stages and DNA fragmentation (TUNEL assay).
    *   The study investigated the role of the mitochondrial permeability transition pore (PTP) using cyclosporine A (CsA).
    *   CsA treatment (which inhibits PTP) significantly reduced the number of perforations (leaf remodeling) and altered mitochondrial dynamics towards a non-PCD state.

4.  **Synthesize the findings:**
    *   The study focuses specifically on the role of mitochondria in PCD in the lace plant.
    *   Mitochondrial dynamics change as PCD progresses (different stages M1-M4 observed in NPCD, EPCD, LPCD cells).
    *   These changes correlate with DNA fragmentation, a hallmark of PCD.
    *   Inhibiting a key mitochondrial function (PTP opening) significantly reduces the PCD phenotype (perforation formation, which is leaf remodeling).

5.  **Formulate the answer:** Based on the evidence, the answer is yes. The text describes a study specifically investigating the role of mitochondria in PCD in the lace plant. The findings show that mitochondrial dynamics change during PCD, correlate with DNA fragmentation, and that inhibiting a mitochondrial process (PTP opening) reduces the PCD phenotype (leaf perforation). Therefore, mitochondria are involved in the process of leaf remodeling during PCD in this plant.

6.  **Refine the answer:** Ensure the answer directly addresses the question and uses information *only* from the provided text. The text strongly implies a role, showing changes in mitochondria during PCD and the effect of inhibiting a mitochondrial function on the PCD outcome (leaf perforation). The answer should reflect this evidence.<unused95>Yes, based on the provided text, mitochondria play a role in remodelling lace plant leaves during programmed cell death (PCD).

Here's the evidence from the text:

1.  **Focus of the Study:** The paper explicitly investigates "the role of mitochondrial dynamics during developmentally regulated PCD in vivo in A. madagascariensis."
2.  **Observed Changes:** Mitochondrial dynamics (distribution, motility, membrane potential) were observed to change as PCD progressed through different stages (EPCD and LPCD) compared to non-PCD cells.
3.  **Correlation with PCD Markers:** These mitochondrial changes correlated with DNA fragmentation (shown by TUNEL assay), a key feature of PCD.
4.  **Functional Evidence:** Treatment with cyclosporine A (CsA), which inhibits the mitochondrial permeability transition pore (PTP), significantly reduced the number of perforations (the leaf remodeling caused by PCD) and altered mitochondrial dynamics towards a non-PCD state.

These findings strongly suggest that mitochondrial dynamics and function, including PTP formation, are involved in the process of leaf perforation (remodeling) during PCD in the lace plant.
